Add To Watchlist
Share URL
Caris Life Sciences, Inc.
CAI: NasdaqGSLowest reading is at 22 out of 100. All scores are out of 100.
In Short
About The Company
CEO
Dr. David Dean Halbert M.D.
Market Cap
9.04 Billion USD
Sector
Healthcare
Website
https://www.carislifesciences.comLast Update
27/09/2026, 17:56:54
Description
Caris Life Sciences, Inc.
Read More
Strongest readings
- ✔Altman-Z score of 6.68 sits above the distress range
- ✔Debt is low at 0.66 times equity
Weakest readings
- ✘Share count has been rising at 34.58% per year
- ✘Price-to-earnings of 55.1 is above the market average of 19.6
- ✘Revenue is growing at 19.53% per year while free cashflow is falling
- ✘The current price sits above estimated fair value (margin of safety -93.45%)
Key Figures
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Price / earnings (TTM) | 55.12x | 19.60x | |
| ✘ | Margin of safety (DCF) | -93.45% | 17.95% | |
| ✔ | Revenue growth (5y average) | 19.53% | 10.97% | |
| ✘ | Dividend yield (TTM) | 0.00% | 1.85% | |
| ✘ | Share count, per year | 34.58% | 0.00% | |
| ✘ | Return on capital employed | 0.83% | 10.00% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Valuation
22 / 100Priced above the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Price / earnings | 55.12x | 19.60x | |
| ✘ | Free cashflow yield | 1.37% | 4.70% | |
| Price / earnings growth | N/A | 1.50x | ||
| Price / book | 15.28x | — | ||
| ✘ | Margin of safety | -93.45% | 17.95% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✘Estimated intrinsic value of 2.09 USD is below the current price of 31.98 USD
Desired Margin Of Safety
0%
▼
Tip: Set your desired Margin Of Safety
Free Cash Flow Type
Annual Cashflow Growth
0%
Discount Rate
0%
Estimated Fair Value: 2.3 USD ✘
Current Price: 32 USD
How Does This Work?
Show Advanced Options
This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated fair value for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel for the impact this has on longterm investment returns and find a margin of safety you are comfortable with.
Growth
57 / 100Growing faster than the market on most measures.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✔ | Revenue growth | 19.53% | 10.97% | |
| ✔ | Earnings growth | 444.63% | 14.48% | |
| ✘ | Cashflow growth | -35.75% | 12.35% |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✔Revenue growth has improved this year (96.36% against a five year average of 19.53%)
- ✘Revenue is growing at 19.53% per year while free cashflow is falling at 35.75% per year
Health
54 / 100Balance sheet covers its obligations.
Measured on Leverage and capital, Funding and liquidity, Earnings quality.
| Status | Metric | Value | Reading | Threshold |
|---|---|---|---|---|
| ✔ | Altman-Z score | 6.68 | 3.00 | |
| ✔ | Piotroski score | 5.00 | 5.00 | |
| ✔ | Debt / equity | 0.66x | 0.80x | |
| ✔ | Current ratio | 5.53x | 1.00x | |
| ✘ | Interest coverage | 0.93x | 2.50x | |
| ✘ | Free cashflow / debt | 0.02x | 0.15x | |
| ✔ | Debt / capital | 0.40x | 1.00x |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Management
25 / 100Returns on capital are below the market.
| Status | Metric | Value | Reading | Market avg |
|---|---|---|---|---|
| ✘ | Return on equity | -0.11% | 15.00% | |
| ✘ | Return on capital employed | 0.83% | 10.00% | |
| Return on assets | -0.05% | — | ||
| Free cashflow return on capital | 0.62% | — | ||
| Return on capital, 5y change | N/A | 0.00% | ||
| ✘ | Share count, per year | 34.58% | 0.00% | |
| ✔ | Share count, recent | -0.07% | 0.00% | |
| Realized buyback return | N/A | 0.00% | ||
| ✔ | Goodwill erosion / equity | 0.00% | 2.00% | |
| Price volatility, 5 year | 65.37% | — |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
- ✔New shares were issued while the value score was 22 out of 100
Analysts
not enough data| Status | Metric | Value | Reading | Neutral |
|---|---|---|---|---|
| Analyst opinion score | N/A | 50 |
The bar shows how good a reading is, so a longer bar is always better. The tick marks the benchmark.
Financial History
Annual figures across the full reporting history we hold.
Market Peers
CAI
SEC Filings
Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.
See 35+ Years Annual ReportsOther Information
Company Name
Caris Life Sciences, Inc.
Currency
USD
Beta
Vol Avg
4884119
Ceo
Dr. David Dean Halbert M.D.
Cik
0002019410
Cusip
Exchange
NasdaqGS
Full Time Employees
1846
Industry
Biotechnology
Sector
Healthcare
Ipo Date
Address
750 West John Carpenter Freeway
City
Irving
State
TX
Country
United States
Zip
75039
Phone
866 771 8946
Analysis Last Updated
27/09/2026, 17:56:54
Financial data compiled from SEC EDGAR filings and Yahoo Finance.